Charles Schwab’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Buy |
111,400
+10,943
| +11% | +$31.6K | ﹤0.01% | 3288 |
|
|
2025
Q1 | $216K | Sell |
100,457
-24,670
| -20% | -$53K | ﹤0.01% | 3251 |
|
|
2024
Q4 | $484K | Hold |
125,127
| – | – | ﹤0.01% | 3150 |
|
|
2024
Q3 | $820K | Sell |
125,127
-2,968
| -2% | -$19.4K | ﹤0.01% | 2983 |
|
|
2024
Q2 | $929K | Buy |
128,095
+45,086
| +54% | +$327K | ﹤0.01% | 2963 |
|
|
2024
Q1 | $630K | Buy |
83,009
+9,246
| +13% | +$70.2K | ﹤0.01% | 2939 |
|
|
2023
Q4 | $336K | Hold |
73,763
| – | – | ﹤0.01% | 3196 |
|
|
2023
Q3 | $291K | Hold |
73,763
| – | – | ﹤0.01% | 3221 |
|
|
2023
Q2 | $231K | Buy |
73,763
+58,626
| +387% | +$183K | ﹤0.01% | 3285 |
|
|
2023
Q1 | $68.6K | Hold |
15,137
| – | – | ﹤0.01% | 3298 |
|
|
2022
Q4 | $62.5K | Buy |
+15,137
| New | +$62.5K | ﹤0.01% | 3317 |
|
|
2019
Q2 | – | Sell |
-4,814
| Closed | -$159K | – | 3249 |
|
|
2019
Q1 | $159K | Sell |
4,814
-834
| -15% | -$27.5K | ﹤0.01% | 3055 |
|
|
2018
Q4 | $336K | Hold |
5,648
| – | – | ﹤0.01% | 2896 |
|
|
2018
Q3 | $793K | Buy |
5,648
+2,098
| +59% | +$295K | ﹤0.01% | 2694 |
|
|
2018
Q2 | $436K | Buy |
+3,550
| New | +$436K | ﹤0.01% | 2846 |
|
|
2017
Q2 | – | Sell |
-3,714
| Closed | -$208K | – | 3123 |
|
|
2017
Q1 | $208K | Hold |
3,714
| – | – | ﹤0.01% | 2922 |
|
|
2016
Q4 | $142K | Hold |
3,714
| – | – | ﹤0.01% | 3015 |
|
|
2016
Q3 | $148K | Sell |
3,714
-2,134
| -36% | -$85K | ﹤0.01% | 2971 |
|
|
2016
Q2 | $421K | Buy |
5,848
+3,875
| +196% | +$279K | ﹤0.01% | 2650 |
|
|
2016
Q1 | $159K | Sell |
1,973
-2,015
| -51% | -$162K | ﹤0.01% | 2941 |
|
|
2015
Q4 | $301K | Sell |
3,988
-428
| -10% | -$32.3K | ﹤0.01% | 2861 |
|
|
2015
Q3 | $1.69M | Buy |
4,416
+2,443
| +124% | +$937K | ﹤0.01% | 2158 |
|
|
2015
Q2 | $820K | Buy |
1,973
+1,056
| +115% | +$439K | ﹤0.01% | 2504 |
|
|
2015
Q1 | $436K | Buy |
917
+209
| +30% | +$99.4K | ﹤0.01% | 2674 |
|
|
2014
Q4 | $263K | Buy |
+708
| New | +$263K | ﹤0.01% | 2896 |
|